Search

Search Constraints

You searched for: Author/Creator Ozaki, Kunihiko

Search Results

1. Circulating Interleukin 6 and Albumin, and Infliximab Levels Are Good Predictors of Recovering Efficacy After Dose Escalation Infliximab Therapy in Patients with Loss of Response to Treatment for Crohn's Disease: A Prospective Clinical Trial. Issue 9 (September 2015)

2. First Trough Level of Infliximab at Week 2 Predicts Future Outcomes of Induction Therapy in Ulcerative Colitis: A Post‐hoc Analysis of a Multicenter Prospective Randomized Controlled Trial: 1851. (October 2015)

3. Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study. Issue 24 (June 2016)

4. Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study. Issue 24 (June 2016)